Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -147,000 | -165,000 | -189,000 | 178,000 | 220,000 |
| Depreciation Amortization | 20,000 | 14,000 | 9,000 | 28,000 | 20,000 |
| Accounts receivable | 31,000 | 34,000 | 36,000 | 79,000 | 86,000 |
| Accounts payable and accrued liabilities | -132,000 | -139,000 | -133,000 | -101,000 | -195,000 |
| Other Working Capital | 29,000 | 14,000 | 34,000 | -79,000 | -155,000 |
| Other Operating Activity | 77,000 | 94,000 | 97,000 | 46,000 | 135,000 |
| Operating Cash Flow | $-122,000 | $-148,000 | $-146,000 | $151,000 | $111,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,000 | N/A | N/A | -7,000 | -3,000 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 4,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 5,000 | 0 |
| Investing Cash Flow | $-2,000 | $N/A | $N/A | $-2,000 | $-3,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,000 | -2,000 | -1,000 | -4,000 | -3,000 |
| Common Stock Issued | 1,000 | 1,000 | 1,000 | N/A | N/A |
| Other Financing Activity | -5,000 | -3,000 | -2,000 | -9,000 | -6,000 |
| Financing Cash Flow | $-7,000 | $-4,000 | $-2,000 | $-13,000 | $-9,000 |
| Beginning Cash Position | 1,060,000 | 1,060,000 | 1,060,000 | 924,000 | 924,000 |
| End Cash Position | 929,000 | 908,000 | 912,000 | 1,060,000 | 1,023,000 |
| Net Cash Flow | $-131,000 | $-152,000 | $-148,000 | $136,000 | $99,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -122,000 | -148,000 | -146,000 | 151,000 | 111,000 |
| Capital Expenditure | -2,000 | N/A | N/A | -7,000 | -3,000 |
| Free Cash Flow | -124,000 | -148,000 | -146,000 | 144,000 | 108,000 |